GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Sudeep Pharma Ltd
Sudeep Pharma Board Meeting Scheduled Aug 4 for Q1 FY27 Results
BOARD ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 25 Jul 2026, 12:52 PM IST  ·  BSE ID: f29e6437-6c02-449f-9fc1-53706b7ca88c
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's directors will meet soon to review and approve the latest financial performance figures.
🤖 AI Summary
  • Sudeep Pharma board meeting scheduled August 4, 2026, to approve Q1 FY27 results.
  • Unaudited standalone and consolidated financial results for quarter ended June 30, 2026, to be considered.
  • Company's trading window closed from July 1, 2026, to August 6, 2026, inclusive.
  • Insider trading code and SEBI regulations govern the trading window closure period.
🏢 How This Affects the Company
⚙️
Operational Impact
The company will maintain restricted trading for its insiders during the results announcement period.
⚠️
Risk Impact
Ensures compliance with SEBI insider trading regulations, mitigating potential risks of information misuse.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders regarding this intimation.
👤
Who Is Affected
All shareholders and persons covered under the company's Insider Trading Code are affected by the trading window closure.
🔍
Management Signal
Management is adhering to regulatory requirements for timely disclosure of financial results and insider trading compliance.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Board meeting results announcement on August 4, 2026.
Trading window reopens on August 7, 2026, post-results.
Next quarter's results announcement for Q2 FY27.
LOW RISK Routine board meeting announcement and trading window closure are standard corporate governance procedures.
💡 Investor Takeaway
Sudeep Pharma Ltd's Board will meet on August 4, 2026, to approve unaudited financial results for the quarter ended June 30, 2026. The trading window is closed until August 6, 2026.
❓ Frequently Asked Questions
When will Sudeep Pharma's Board of Directors meet?
Sudeep Pharma's Board of Directors meeting is scheduled for Tuesday, August 4, 2026.
What will be discussed at the Sudeep Pharma board meeting?
The board will consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.
What are the dates for Sudeep Pharma's trading window closure?
The trading window for Sudeep Pharma is closed from Wednesday, July 1, 2026, until Thursday, August 6, 2026, both days inclusive.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.